Clinical Trials Directory

Trials / Completed

CompletedNCT05535270

Validation of the Chinese Version of Oxford Depression Questionnaire

Psychometric Properties of the Oxford Depression Questionnaire in Chinese Patients With Mood Disorders

Status
Completed
Phase
Study type
Observational
Enrollment
272 (actual)
Sponsor
First Affiliated Hospital of Zhejiang University · Academic / Other
Sex
All
Age
13 Years – 65 Years
Healthy volunteers
Accepted

Summary

Mood disorders are a group of psychiatric disorders that can affect a person's mood, energy, and motivation. Emotional blunting has been observed in clinical practice in patients with mood disorders. Emotional blunting has a negative impact on patients' overall treatment and leads to poorer adherence. The Oxford Depression Questionnaire (ODQ) is a measuring instrument of emotional blunting. The ODQ is expected to be a scientifically valid tool for detecting emotional blunting. The ODQ has high construct validity and internal reliability. However, no scientific validity studies have been conducted on ODQ in Chinese population. Therefore, this study is intended to investigate the reliability and validity of the ODQ in Chinese patients with mood disorders.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOxford Depression Questionnaire (ODQ)The Oxford Depression Questionnaire (ODQ)is a patient-centered questionnaire. The scale contains three sections: i) the patient's experience in the past week; ii) the patient's experience before the illness worsened, and iii) the patient's emotional feelings about receiving antidepressant treatment. The 26-item questionnaire contains four dimensions of "emotional blunting": not caring (NC), emotional detachment from others (ED), reduction in positive emotions (RP), and general reduction in emotions (GR). Patients not taking antidepressants were only required to rate the first two sections .

Timeline

Start date
2022-01-01
Primary completion
2023-06-01
Completion
2023-06-30
First posted
2022-09-10
Last updated
2023-09-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05535270. Inclusion in this directory is not an endorsement.